Tennessee Oncology, PLLC
Gallatin, Tennessee, United States
Medical clinic in Gallatin, Tennessee
225 Big Station Camp Blvd #201, Gallatin, TN 37066
About Tennessee Oncology, PLLC
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Tennessee Oncology, PLLC
During the past decade, Tennessee Oncology, PLLC conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 12 clinical trials were completed, i.e. on
average, 109.1% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
2017-12-19
2024-06-30
Active, not recruiting
1,550
Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A
2018-03-16
2023-02-07
Terminated
1,382
Phase 3 Study of Sitravatinib Plus Nivolumab vs Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
2019-07-15
2023-07-01
Active, not recruiting
532
Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss
2020-06-08
2024-06-19
Active, not recruiting
137
Trilaciclib, a CDK4/6 Inhibitor, in Patients With Early-Stage Triple Negative Breast Cancer
2021-11-19
2023-03-13
Completed
24
Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer
2022-03-11
2026-02-16
Recruiting
350
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)
2022-04-14
2027-10-01
Recruiting
900
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Tennessee Oncology, PLLC"
#1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 2 trials as a collaborator, "Kyowa Kirin Co., Ltd." with 1 trials as a collaborator, "Medivation, Inc." with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Tennessee Oncology, PLLC
According to Clinical.Site data, the most researched conditions in "Tennessee Oncology, PLLC" are
"Carcinoma, Non-Small-Cell Lung" (4 trials), "Ovarian Cancer" (3 trials), "Breast Neoplasms" (2 trials), "Triple Negative Breast Cancer" (2 trials) and "Advanced, Androgen Receptor Positive Triple Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Tennessee Oncology, PLLC" in a lesser frequency.
Clinical Trials Intervention Types at Tennessee Oncology, PLLC
Most popular intervention types in "Tennessee Oncology, PLLC" are "Drug" (22 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Avelumab" (2 trials), "Carboplatin" (2 trials), "Enzalutamide" (2 trials), "Gemcitabine" (2 trials) and "PF-02341066" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Tennessee Oncology, PLLC
The vast majority of trials in "Tennessee Oncology, PLLC" are
15 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Tennessee Oncology, PLLC
Currently, there are NaN active trials in "Tennessee Oncology, PLLC".
undefined are not yet recruiting,
2 are recruiting,
6 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 11 completed trials in Tennessee Oncology, PLLC,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Tennessee Oncology, PLLC, 2 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 14 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".